Europe Molecular Diagnostic Market

Molecular Diagnostic Market for Group A
Streptococcus (GAS) Nucleic Acid (NA) Test
Products - Europe Industry Analysis, Size,
Share, Growth, Trends, and Forecast, 2015
- 2023
According to a new market report published by Transparency
Market Research “Molecular Diagnostic Market for Group A
Streptococcus (GAS) Nucleic Acid (NA) Test Products Market -
Europe Industry Analysis, Size, Share, Growth, Trends, and
Forecast, 2015 - 2023”, the Europe molecular diagnostic market
for group A streptococcus (GAS) nucleic acid (NA) test products
market was valued at US$ 8.3 Mn in 2014 and is projected to
expand at a CAGR of 11.6% from 2015 to 2023 to reach US$
22.3 Mn in 2023.
Rapid and accurate diagnosis is a key factor for effective disease
treatment. Increasing incidence of Streptococcus pyogenes
infection in Europe, advancement of technology, and rising
demand for point-of-care testing act as a high impact drivers of
the market.
Advancements in techniques such as isothermal nucleic acid
amplification tests is likely to propel the market during the
forecast period. The molecular diagnostic market for group A

streptococcus (GAS) nucleic acid (NA) test in Europe has been
segmented based on type of test technique, end-user, and region.
Browse Full Research Report on Europe Molecular
Diagnostic Market:
http://www.transparencymarketresearch.com/europe-moleculardiagnostic-market.html
A study conducted by the American Society for Microbiology
concluded that incidence rate of Streptococcus pyogenes is high
in countries in Northern Europe. The incidence of the disease
has increased at a steady rate in most of these countries of the
market. The automated detection system offers a faster, more
flexible, and cost-effective solution to clinicians.
Advancement of technology is bringing testing services to pointof-care.
Due to its high sensitivity and accuracy the tests are
backs up all negative rapid antigen assays. The Advancements in
nucleic acid testing technologies and their adoption in Europe
would result in high growth adoption of the technology will
primarily occur in the developed countries. Ineffectiveness and
slow adoption are the major restraints of the market.
The polymerase chain reaction segment held the largest share of
the market in 2014, followed by the non-amplified tests
segment. PCR is a traditional technology used for nucleic acid
tests. However, the new, efficient, and user-friendly methods,

such as isothermal nucleic acid amplification and non-amplified
tests, are likely to capture higher market share in the near future.
Isothermal nucleic acid amplification technology has been
identified as the fastest growing segment during the forecast
period due to its accuracy and rapid identification.
Nucleic acid amplification techniques take tiny amounts of DNA
or RNA, replicate them many times, and thus can detect minute
traces of an organism in a specimen, avoiding the need for
culture. Non-amplified technology using hybridization probe
would capture a decent share in the market during the forecast
period.
The hospitals end-user segment accounted for over 58.2% share
of the nucleic acid (NA) test products market in Europe in terms
of revenue in 2014, followed by the public health laboratories
segment. Moreover, the segment is expected to gain market
share and emerge as the fastest growing segment during the
forecast period.
Western Europe was the largest market for nucleic acid (NA)
test products in 2014, accounting for around 48.9% share.
Western Europe dominated the market due to highly developed

health care infrastructure and favorable reimbursement scenario.
On the other hand, Northern Europe is expected to gain high
market share during the forecast period owing to increase in
incidence of Streptococcus pyogenes infection and high
adoption rate.
Alere, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Meridian
Bioscience, Inc., Nanosphere, Inc., and Quidel Corporation are
the major players operating in European Molecular Diagnostic
Market for Group A Streptococcus (GAS) Nucleic Acid (NA)
Test Products market.
Browse Full Press Release on Europe Molecular Diagnostic Market :
Press Release
About Us
Transparency Market Research (TMR) is a global market
intelligence company providing business information reports
and services. The company’s exclusive blend of quantitative
forecasting and trend analysis provides forward-looking insight
for thousands of decision makers. TMR’s experienced team of
analysts, researchers, and consultants use proprietary data
sources and various tools and techniques to gather and analyze
information.

TMR’s data repository is continuously updated and revised by a
team of research experts so that it always reflects the latest
trends and information. With extensive research and analysis
capabilities, Transparency Market Research employs rigorous
primary and secondary research techniques to develop
distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com